Allium Medical (TASE: ALMD) - an Israeli medical device company that specializes in minimally invasive technologies and solutions, announced today that it received regulatory clearance from the China ...

Caesarea, Israel -Nov. 6, 2008 - Allium Medical Group, developer and manufacturer of anatomically and functionally compatible, dynamic, large-caliber, removable stents, announced today the appointment ...

Allium is looking for a strategic transaction, preferably M&A; we believe the FDA approval could make Gardia more attractive to potential partners. We model Wirion as part of Allium’s overall business ...

A nephroureteral stent, sometimes as well called ureteric stent, it’s a thin tube inserted into the ureter to prevent or treat obstruction of the urine flow due to conditions such as kidney stone, ...

The urinary stents industry size is expected to grow at a 4.4% compound annual growth rate (CAGR) from 2022 to 2032, reaching US$ 385.9 million in 2022 and US$ 616.8 million at that point. Ureteric ...

SEATTLE, UNITED STATES, UNITED STATES, September 20, 2022 /EINPresswire.com / -- Non-vascular stents are a type of medical device that can be implanted in the oesophagus, biliary tract, colon, trachea ...

This increase comes mainly from Allium Stents and IBI Medical. We are encouraged to see that the company continued to execute on its business plan of organic growth and margin expansion; therefore, ...

The Company has a strategic agreement with a leading Urology distribution partner Allium Medical (TASE: ALMD) - an Israeli medical device company that specializes in minimally invasive technologies ...

* ALLIUM MEDICAL - HAS EXCLUSIVE STRATEGIC AGREEMENT WITH DISTRIBUTION ORGANIZATION IN CHINA, EXPECTS TO GENERATE SIGNIFICANT REVENUE IN 2018 Source text for Eikon: Further company coverage: ...